BNP Paribas Financial Markets’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Buy
9,856
+8,435
+594% +$125K ﹤0.01% 4396
2026
Q1
$21.9K Buy
1,421
+400
+39% +$6.66K ﹤0.01% 5061
2025
Q4
$18.4K Buy
1,021
+421
+70% +$7.24K ﹤0.01% 5044
2025
Q3
$9.67K Sell
600
-5,482
-90% -$80.2K ﹤0.01% 5019
2025
Q2
$66.2K Sell
6,082
-2,792
-31% -$31.3K ﹤0.01% 4154
2025
Q1
$111K Buy
8,874
+6,274
+241% +$103K ﹤0.01% 3998
2024
Q4
$51.5K Buy
2,600
+2,597
+86,567% +$28.8K ﹤0.01% 4418
2024
Q3
$25 Buy
+3
New +$20 ﹤0.01% 4102
2023
Q3
Sell
-1,562
Closed -$12.2K 3994
2023
Q2
$12.2K Buy
1,562
+1,502
+2,503% +$10.7K ﹤0.01% 3617
2023
Q1
$392 Hold
60
﹤0.01% 3731
2022
Q4
$346 Buy
+60
New +$375 ﹤0.01% 3889

Other funds holding MESO

BNP Paribas Financial Markets's MESO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Mesoblast (MESO) stake by 594% in Q2 2026, buying an estimated $125K and bringing the position to 9,856 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #4396.

BNP Paribas Financial Markets first reported a position in MESO in Q4 2022 and has held it in 11 quarters since. 68 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • BNP Paribas Financial Markets held 9,856 shares of Mesoblast worth $133K as of Q2 2026.
  • BNP Paribas Financial Markets bought 8,435 Mesoblast shares in Q2 2026, an estimated $125K.
  • Mesoblast made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4396 holding.
  • BNP Paribas Financial Markets first reported a position in Mesoblast in Q4 2022 and has held it in 11 quarters since.
  • 68 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.